Oncimmune

We understand disease through the lens of the human immune system, to enable more effective, safer treatments & better diagnosis #immunoINSIGHTS #Biomarkers

[Oncimmune @OncimmuneII]

#Didyouknow #Autoantibodies can be found in clinically & immunologically opposing diseases, such as #autoimmune diseases & #cancer. Often referred to as anti-tumor #antibodies, or tumor-associated antibodies, they are implicated heavily in cancer #immunity https://t.co/IPFb4IXGdS

[Oncimmune @OncimmuneII]

Discover ImmunoINSIGHTS™, the leading biomarker discovery platform that works to detect novel #autoantibody signatures for immunooncology, autoimmune and infectious diseases. https://t.co/mfZfQbJPy5 #ImmunoINSIGHTS #Biomarkers #ImmuneBiomarkers #Autoantibodies

[Oncimmune @OncimmuneII]

To all our new followers, a warm welcome! At Oncimmune our team comes together to provide a better understanding of the immune response to therapies, improve clinical trial outcomes & support the development of safer treatments for patients. https://t.co/FNAiBCR7Q6

[Oncimmune @OncimmuneII]

Oncimmune is thrilled to participate and meet customers at the upcoming 2023 American Society of Clinical Oncology #ASCO23 Annual Meeting, to be held in-person on June 2-6, 2023, in Chicago, Illinois. Visit us at booth 18156! https://t.co/mNjE6voAfa #ImmunoINSIGHTS

[Oncimmune @OncimmuneII]

#Didyouknow #Autoantibodies can be found in clinically & immunologically opposing diseases, such as #autoimmune diseases & #cancer. Often referred to as anti-tumor #antibodies, or tumor-associated antibodies, they are implicated heavily in cancer #immunity https://t.co/IPFb4IXGdS

[Oncimmune @OncimmuneII]

Discover ImmunoINSIGHTS™, the leading biomarker discovery platform that works to detect novel #autoantibody signatures for immunooncology, autoimmune and infectious diseases. https://t.co/mfZfQbJPy5 #ImmunoINSIGHTS #Biomarkers #ImmuneBiomarkers #Autoantibodies

[Oncimmune @OncimmuneII]

To all our new followers, a warm welcome! At Oncimmune our team comes together to provide a better understanding of the immune response to therapies, improve clinical trial outcomes & support the development of safer treatments for patients. https://t.co/FNAiBCR7Q6

[Oncimmune @OncimmuneII]

Attending #BioEuropeSpring in #Basel ? Connect with @MikeFisherPhD our VP and Head of business development to learn more how #ImmunoINSIGHTS autoantibody biomarker discovery platform. https://t.co/qWEyVuIPo5 #Autoantibodies
#Biomarkers #Biotechnology

[Oncimmune @OncimmuneII]

#Fridayread Adrenal insufficiency is an endocrine immune-related adverse event that can be induced by #checkpointinhibitors causing deficiency of adrenal cortisol production. This review highlights mechanisms & #autoantibodies associated wt AI. https://t.co/OGO8I56sTS

[Oncimmune @OncimmuneII]

#FridayRead #autoantibodies in patients infected with #SARSCoV2 Anti-chemokine autoantibodies are likely to be associated with better outcome following SARS-CoV-2 infection compared to patients with #longCOVID. https://t.co/3uhcp5qmQi

[Oncimmune @OncimmuneII]

Oncimmune is attending #BioEuropeSpring conference March 20-23 in Basel! Make sure to take the opportunity to connect with @MikeFisherPhD
VP and Head of Business Development.

👉 https://t.co/3Qpf28UmDs

#ImmunoINSIGHTS
#Autoantibodies
#Biomarkers
#Biotechnology

[Oncimmune @OncimmuneII]

Today we celebrate the achievements of women who innovate, lead, and inspire! Happy #InternationalWomenDay to all our colleagues, inspiring women working to support our mission, to improve the understanding of the #immunesystem and advance #precisionmedicine. #WomenInSTEM

[Oncimmune @OncimmuneII]

#Fridayreads Evidence that elevated #IFNα levels act directly on B cells to facilitate #autoantibody production & further highlight the importance of IFN signaling as a potential therapeutic target in #Systemiclupuserythematosus #SLE https://t.co/YyQaCbRW9G #ImmunoINSIGHTS

[Oncimmune @OncimmuneII]

#FridayReads This review on T cell response in #autoimmunity and #cancer highlights interplay from these two diseases and how they can provide answers to improve the application, efficacy, and management of #immunotherapies #biomarkers #autoantibodies
https://t.co/LYEod5C4vq

[British In Vitro Diagnostics Association (BIVDA) @BIVDA]

BIVDA member @OncimmuneECDT received a Queen’s Award for Enterprise in Innovation 2022 by Sir John Peace, the Lord-Lieutenant of Nottinghamshire, today.

What a great achievement, congratulations from all at BIVDA!

[ABHI @UK_ABHI]

ABHI member @OncimmuneECDT received a Queen’s Award for Enterprise in Innovation 2022 by Sir John Peace, the Lord-Lieutenant of Nottinghamshire, today.

What a great achievement, congratulations from all at ABHI!

[Oncimmune @OncimmuneII]

We're thrilled to have received the @TheQueensAwards for Enterprise in Innovation 2022 awarded by Sir John Peace, the @Lord_Lt_Notts at our Nottingham laboratories! Thanks to all our staff who have made this great achievement possible! @LordMayorNottm #TeamOncimmune

[Oncimmune @OncimmuneII]

Are you attending #IO360nyc ? Make sure to meet our team at booth 18. Learn more about the #ImmunoINSIGHTS platform and how it provides relevant immune #biomarker insights for your clinical programs. #celltherapy #cancerresearch #clinicaltrials #immunooncology

[Oncimmune @OncimmuneII]

Nice review on the interplay of immune #checkpointinhibitors ICI therapies #toxicities #cancer. #BCells & #antibodies against autologous antigens (#autoantibodies) advances as emerging #biomarkers to predict immune-related #adverseevents #irAEs https://t.co/pKeXmR1T1T

[Oncimmune @OncimmuneII]

We’re excited to be exhibiting on Feb 7-10th at the #IO360nyc ! Come and meet with our team at booth #18 𝑾𝒆’𝒓𝒆 𝒍𝒐𝒐𝒌𝒊𝒏𝒈 𝒇𝒐𝒓𝒘𝒂𝒓𝒅 𝒕𝒐 𝒔𝒆𝒆 𝒚𝒐𝒖 𝒕𝒉𝒆𝒓𝒆! #Oncimmune #ImmunoINSIGHTS #biomarkers
#cancerimmunotherapy #clinicaltrials #precisiononcology